A call for quality as volatility turns up the volume
By Russ Koesterich, BlackRock’s Global Chief Investment Strategist
Stocks struggle again
Stocks mounted more losses last week amid sharp intraday gyrations. The tech-heavy Nasdaq Composite Index fared the worst, falling 2.92% to end the week at 4,686, while the S&P 500 Index dropped 1.38% to 1,931 and the Dow Jones Industrial Average declined 0.43% to 16,314. Meanwhile, the yield on the 10-year Treasury rose from 2.13% to 2.16%, as its price correspondingly fell.
What was different last week, unlike most of the past few months, was that markets were contending primarily with issues specific to individual stocks and sectors. Overall, investors should expect the current high-volatility environment to persist—regardless of the cause.
The economic data came in mixed last week. There was a weak Chicago Fed National Activity Index report and soft existing home sales, but second-quarter gross domestic product revisions were positive. While this played a role in the market’s struggles, the real catalysts were at the industry level.
Biotech stocks traded down close to their August lows, near bear market territory, following a tweet from Hillary Clinton that raised the specter of price controls in the biotech sector. Stocks in Europe, particularly automakers, were punished on the back of the Volkswagen emissions cheating scandal. Finally, industrial bellwether Caterpillar lowered its revenue forecast and announced 10,000 job cuts, putting US industrial companies under pressure.